TY - JOUR
T1 - The Effects of Naloxone on Retinal Ischemia in Rats
AU - Lam, Tim T.
AU - Takahashi, Kanji
AU - Tso, Mark O.m.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1994
Y1 - 1994
N2 - The efficacy of naloxone (NL), a broad spectrum opioid antagonist, on retinal ischemia, was evaluated in a rat model of retinal ischemia with histopathologic and morphometric criteria. Two intraperitoneal injections of naloxone 3 mg/kg given immediately and 6 hr after reperfusion showed beneficial effects to the retina as evaluated at 2, 7, and 14 days after reperfusion. Morphologically, the naloxone-treated group showed better-preserved ganglion cells, nerve fiber layer, and inner nuclear layer. Morphometrically, in the treated groups, inner retinal thickness at all three time points and ganglion cell counts at 7 days showed higher values than vehicle controls. This beneficial effect of naloxone was dose-dependent with a minimal effective total dose of 6 mg/kg. A possible role of opiate receptors in retinal ischemia is suggested.
AB - The efficacy of naloxone (NL), a broad spectrum opioid antagonist, on retinal ischemia, was evaluated in a rat model of retinal ischemia with histopathologic and morphometric criteria. Two intraperitoneal injections of naloxone 3 mg/kg given immediately and 6 hr after reperfusion showed beneficial effects to the retina as evaluated at 2, 7, and 14 days after reperfusion. Morphologically, the naloxone-treated group showed better-preserved ganglion cells, nerve fiber layer, and inner nuclear layer. Morphometrically, in the treated groups, inner retinal thickness at all three time points and ganglion cell counts at 7 days showed higher values than vehicle controls. This beneficial effect of naloxone was dose-dependent with a minimal effective total dose of 6 mg/kg. A possible role of opiate receptors in retinal ischemia is suggested.
UR - http://www.scopus.com/inward/record.url?scp=0028308271&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028308271&partnerID=8YFLogxK
U2 - 10.1089/jop.1994.10.481
DO - 10.1089/jop.1994.10.481
M3 - Article
C2 - 8083567
AN - SCOPUS:0028308271
SN - 8756-3320
VL - 10
SP - 481
EP - 492
JO - Journal of Ocular Pharmacology
JF - Journal of Ocular Pharmacology
IS - 2
ER -